Usefulness of Atrial Fibrillation as a Marker for Adverse Cardiovascular Outcomes in Both Primary and Secondary Prevention in Patients With Implantable Cardioverter-Defibrillators
2016 ◽
Vol 118
(10)
◽
pp. 1497-1502
◽
2003 ◽
Vol 138
(6)
◽
pp. 445
◽
2021 ◽
Vol 16
(4)
◽